ABRYSVO

· Pfizer

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for ABRYSVO, covering 2025-10-02 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Abrysvo (respiratory syncytial virus vaccine (bivalent, recombinant)) — Pfizer Europe MA EEIG